Correspondence 0001683168-24-007458 from Marquie Group, Inc. (TMGI) (CIK 0001434601) (TMGI)
Marquie Group, Inc. (TMGI) (CIK 0001434601)
Date: Oct. 29, 2024 · CIK: 0001434601 · Accession: 0001683168-24-007458
AI Filing Summary & Sentiment
File numbers found in text: 333-282485
Referenced dates: October 17, 2024
Show Raw Text
CORRESP
1
filename1.htm
The
Marquie Group, Inc.
7901 4th Street North, Suite 4887
St. Petersburg, FL 33702
October 24, 2024
Division of Corporation Finance
Securities and Exchange Commission
Re:
Marquie Group, Inc.
Registration
Statement on Form S-1
Filed October
3, 2024
File No.
333-282485
Dear Sir/Madam:
In response to
your letter dated October 17, 2024, the following information is hereby submitted on behalf of The Marquie Group, Inc. (the "Company").
Amendment No. 1 to the Registration Statement on S-1 is being filed in conjunction with this correspondence. For your convenience, we
have reproduced the Staff's comments below in italicized text immediately before our response.
Registration Statement on Form S-1
Cover Page
1. Your disclosure that the selling stockholder "is not a broker-dealer, is
not an affiliate of a broker dealer, and does not have any agreement or understanding, directly or indirectly, with any person to distribute
our common stock" is inconsistent with your disclosure on page 9 that the selling stockholder is an underwriter. Please revise or
advise.
Response: We have updated
the Registration Statement as requested.
Forward-Looking Statements and Projections, page 1
2. Please remove your references here and on page 17 to forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. As an issuer of penny stock you do not appear to be eligible
to rely on the safe harbors provided by these sections.
Response: We have removed
references to the PSLRA. However, in the spirit of full disclosure to the general public, we believe the forward-looking statement disclosure
should still be included in the registration statement even if the safe harbor protections do not apply.
Risk Factors, page 5
3. Please add risk factor disclosure acknowledging that your auditor, Olayinka Oyebola
& Co. (Chartered Accountants), and its principal, Olayinka Oyebola, have been charged by the Securities and Exchange Commission with
aiding and abetting violations of the antifraud provisions of the federal securities laws. Acknowledge that the relief sought includes
potential civil penalties as well as permanent injunctive relief, including an order permanently barring your auditor from acting as an
auditor or accountant for U.S. public companies or providing substantial assistance in the preparation of financial statements filed with
the Securities and Exchange Commission. Explain how such charges and such penalties, if imposed, would impact you and any investment in
your securities. Refer to the Securities and Exchange Commission’s press release, available at https://www.sec.gov/newsroom/pressreleases/2024-157.
Response: We have updated the
Registration Statement as requested.
1
Plan of Distribution, page 9
4. We note your disclosure that the selling stockholders may utilize "purchases
by a broker-dealer as principal and resale by the broker-dealer for its account.” Please confirm your understanding that the retention
by a selling stockholder of a broker- dealer would constitute a material change to your plan of distribution requiring a post- effective
amendment. Refer to your undertaking provided pursuant to Item 512(a)(1)(iii) of Regulation S-K.
Response: We confirm we understand that the retention
of a broker-dealer by a selling stockholder would constitute a material change to our plan of distribution and, thus, would require an
amendment to this Registration Statement. (See Item 17 UNDERTAKINGS, Paragraph 1(iii)).
Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters, page 30
5. Please revise to include the Series A preferred stock in the beneficial ownership
table and add cover page disclosure regarding the fact that the ownership of these preferred shares gives Mr. Angell control of the Company.
Refer to Item 403(a) of Regulation S-K.
Response: We have updated the Registration Statement
as requested.
General
6. Given the nature of your offering, including the size of the shares outstanding
and the amount of shares you are registering, it appears that the transaction may be an indirect primary offering on behalf of the registrant.
Please provide us with a detailed legal analysis of your basis for determining that it is appropriate to characterize the transaction
as a secondary offering under Securities Act Rule 415(a)(1)(i). For guidance, review Compliance &Disclosure Interpretations 612.09.
Response: Pursuant to Compliance
& Disclosure Interpretations 612.09, “[t]he question of whether an offering styled a secondary one is really on behalf of
the issuer is a difficult factual one, not merely a question of who receives the proceeds. Consideration should be given to how long the
selling shareholders have held the shares, the circumstances under which they received them, their relationship to the issuer, the amount
of shares involved, whether the sellers are in the business of underwriting securities, and finally, whether under all the circumstances
it appears that the seller is acting as a conduit for the issuer.”
In the present case, the selling
shareholder made several loans to the Company in exchange for convertible promissory notes. The notes have issuance dates ranging from
June 2022 through May 2024. Rule 144(d)(3)(ii) states, “If the securities…were acquired from the issuer solely in exchange
for other securities of the same issuer, the newly acquired securities shall be deemed to have been acquired at the same time as the securities
surrendered for conversion or exchange.” Based on this Rule, the shares, when issued, will be deemed to have been issued when the
parties originally exchanged the consideration associated with the respective notes. Furthermore, the selling shareholders are not in
the business of underwriting securities, nor do they have any relationship with the Company aside from the few loans extended. Finally,
while this is not merely a question of who receives the proceeds, it bears mentioning that the Company will not receive any proceeds from
the offering. Here, our counsel is of the opinion that each of these factors weigh against the finding of an indirect offering on behalf
of the registrant.
We concede that, on its face, the
number of shares being registered in the offering does weigh in favor of the finding of an indirect offer on behalf of the registrant.
However, there are many factors at play that will ultimately influence whether any shares are issued. Some of these factors include, but
are not limited to, market conditions, liquidity, and any cash repayments made by the Company. Based on the totality of the circumstances
and in weighing all factors for and against the finding of an indirect offering, we believe there is sufficient evidence against the finding
of an indirect offering on behalf of the issuer.
2
7. You disclose in your filing that the selling stockholder may offer shares at
"prevailing market prices." You also disclose that your common stock is quoted on the OTC Pink marketplace. Please note that
an at-the-market resale offering under Rule 415 is not available for registrants quoted on the OTC Pink marketplace because the OTC Pink
marketplace is not an established trading market for purposes of satisfying Item 501(b)(3) of Regulation S-K. Please revise your prospectus
to disclose a fixed price at which the selling stockholder will offer and sell its shares until your shares are listed on a national securities
exchange or quoted on the OTC Bulletin Board, OTCQX, or OTCQB, at which time they may be sold at prevailing market prices.
Response: We have removed
the reference to prevailing market prices and have replaced it with an offering price of $0.0001, which is consistent throughout the Registration
Statement.
We are aware that the Company
and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff. Please let me know if you need anything further.
Sincerely,
The
Marquie Group, Inc.
/s/ Marc Angell
CEO and Director
3